Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-84b7d79bbc-tsvsl Total loading time: 0 Render date: 2024-07-26T12:23:24.687Z Has data issue: false hasContentIssue false

Levetiracetam

Published online by Cambridge University Press:  04 August 2010

Philip N. Patsalos  and
Blaise F. D. Bourgeois
Philip N. Patsalos
Affiliation:
Chalfont Centre for Epilepsy, Buckinghamshire, UK
Blaise F. D. Bourgeois
Affiliation:
Harvard Medical School, Boston
Get access
Type
Chapter
Information
The Epilepsy Prescriber's Guide to Antiepileptic Drugs , pp. 124 - 133
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ben-Menachem, E, Falter, U; for the European Levetiracetam Study Group. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia 2000; 41: 1276–1283.CrossRefGoogle ScholarPubMed
Berkovic, SF, Knowlton, RC, Leroy, RF, Schiemann, J, Falter, U; Levetiracetam N01057 Study Group. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007; 69: 1751–1760.CrossRefGoogle ScholarPubMed
Brodie, MJ, Perucca, E, Ryvlin, P, Ben-Menachem, E, Meencke, HJ; Levetiracetam Monotherapy Study Group. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007; 68: 402–408.CrossRefGoogle ScholarPubMed
Gallagher, MJ, Eisenman, LN, Brown, KM, Erbayat-Altay, E, Hecimovic, H, Fessler, AJ, Attarian, HP, Gilliam, FG. Levetiracetam reduces spike-wave density and duration during continuous EEG monitoring in patients with idiopathic generalized epilepsy. Epilepsia 2004; 45: 90–91.CrossRefGoogle ScholarPubMed
Johannessen, Landmark C, Patsalos, PN. Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Reviews in Neurotherapeutics 2010; 10: 119–140.CrossRefGoogle Scholar
Kossoff, EH, Bergey, GK, Freeman, JM, Vining, EP. Levetiracetam psychosis in children with epilepsy. Epilepsia 2001; 42: 1611–1613.CrossRefGoogle ScholarPubMed
Patsalos, PN. Anti-epileptic drug interactions. A clinical guide. Clarius Press: Guildford, UK; 2005.Google Scholar
Patsalos, PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacology and Therapeutics 2000; 85: 77–85.CrossRefGoogle ScholarPubMed
Patsalos, PN. Clinical pharmacokinetics of levetiracetam. Clinical Pharmacokinetics 2004; 43: 707–724.CrossRefGoogle ScholarPubMed
Patsalos, PN. Levetiracetam: pharmacology and therapeutics in the treatment of epilepsy and other neurological conditions. Reviews in Contemporary Pharmacotherapy 2004; 13: 1–168.Google Scholar
Patsalos, PN, Ghattura, S, Ratnaraj, N, Sander, JW. In situ metabolism of levetiracetam in blood of patients with epilepsy. Epilepsia 2006; 47: 1818–1821.CrossRefGoogle ScholarPubMed
Pellock, JM, Glauser, TA, Bebin, EM, Fountain, NB, Ritter, FJ, Coupez, RM, Shileds, WD. Pharmacokinetic study of levetiracetam in children. Epilepsia 2001; 42: 1574–1579.CrossRefGoogle ScholarPubMed
Rocamora, R, Wagner, K, Schulze-Bonhage, A. Levetiracetam reduces frequency and duration of epileptic activity in patients with refractory primary generalized epilepsy. Seizure 2006; 15: 428–433.CrossRefGoogle ScholarPubMed
Shorvon, SD, Löwenthal, A, Janz, D, Bielen, E, Loiseau, P; for the European Levetiracetam Study Group. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia 2000; 41: 1179–1186.CrossRefGoogle ScholarPubMed
Specchio, LM, Gambardella, A, Giallonardo, AT, Michelucci, R, Specchio, N, Boero, G, Neve, A. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy. Epilepsy Research 2006; 71: 32–39.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×